Gyre Therapeutics (GYRE) EBIT Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,386.07% |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | -511.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -511.57% |
| Dec 31, 2025 | -1,353.68% |
| Sep 30, 2025 | 63.60% |
| Jun 30, 2025 | -32.03% |
| Mar 31, 2025 | -71.84% |
| Dec 31, 2024 | 100.73% |
| Sep 30, 2024 | -66.84% |
| Jun 30, 2024 | -35.79% |
| Mar 31, 2024 | 21.11% |
| Dec 31, 2023 | -307.98% |
| Sep 30, 2023 | 347.08% |
| Jun 30, 2023 | -90.35% |
| Mar 31, 2023 | 145.33% |
| Dec 31, 2022 | -10.57% |
| Sep 30, 2022 | 79.52% |
| Jun 30, 2022 | 358.76% |
| Mar 31, 2022 | 34.48% |
| Dec 31, 2021 | -7.81% |
| Sep 30, 2021 | -56.70% |
| Jun 30, 2021 | -14.71% |
| Mar 31, 2021 | -342.74% |
| Dec 31, 2020 | -34.70% |
| Sep 30, 2020 | -22.02% |
| Jun 30, 2020 | -20.72% |
| Mar 31, 2020 | 67.75% |
| Dec 31, 2019 | -19.71% |
| Sep 30, 2019 | -58.12% |
| Jun 30, 2019 | -102.15% |
| Mar 31, 2019 | -135.27% |
| Dec 31, 2018 | -100.45% |
| Sep 30, 2018 | -41.97% |
| Jun 30, 2018 | -19.68% |
| Mar 31, 2018 | -60.13% |
| Dec 31, 2017 | -11.67% |
| Sep 30, 2017 | -2.91% |
| Jun 30, 2017 | -20.94% |
| Mar 31, 2017 | 8.77% |
| Dec 31, 2016 | -11.47% |
| Sep 30, 2016 | -47.03% |
| Jun 30, 2016 | -123.31% |
| Mar 31, 2016 | -50.79% |
| Dec 31, 2015 | -160.46% |
| Sep 30, 2015 | -137.18% |
| Jun 30, 2015 | 0.41% |
| Mar 31, 2015 | -62.75% |
| Dec 31, 2014 | 86.49% |
| Sep 30, 2014 | 87.54% |
| Jun 30, 2014 | 82.30% |
| Mar 31, 2014 | 77.48% |
| Dec 31, 2013 | 18.15% |
| Sep 30, 2013 | -62.34% |
| Jun 30, 2013 | -187.73% |
| Mar 31, 2013 | -516.62% |
| Dec 31, 2012 | -60.28% |
| Sep 30, 2012 | 13.21% |
| Jun 30, 2012 | 653.64% |
| Mar 31, 2012 | -83.86% |
| Dec 31, 2011 | -647.61% |
| Sep 30, 2011 | -486.06% |
| Jun 30, 2011 | -151.77% |